Home › Breast Cancer › NCT05766891
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
RecruitingPhase 2/3
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Men and Women; 2. Age 18 or older; 3. Scheduled for a unilateral, breast surgical procedure, ± SLND 4. Able to read, write and speak English or Spanish 5. Able to sign a written informed consent and be willing to follow protocol requirements Exclusion Criteria: 1. Extreme mobility issues that preclude participating in the study 2. Major thought disorders such as schizophrenia or uncontrolled bipolar disorder or PTSD 3. History of chronic opioid use 4. Current pain 2 or above on 0-10 scale 5. Co-mobilities such as uncontrollable diabetes or hypertension 6. Plastic surgery involvement for oncoplastic reconstruction 7. Surgery is likely greater than 3 hours 8. Patients with hearing loss that could preclude HS facilitation 9. Known allergy to propofol or other medications used during surgery
About the study
To hypnosedation alone given before and during surgery on reducing opioid use after surgery compared to standard general anesthesia given alone or with hypnosedation.
What is being tested
- Group 1 (behavioral)
- Group 2 (behavioral)
- Group 3 (behavioral)
Sponsor: M.D. Anderson Cancer Center · Participants: 225 · Started: Oct 12, 2023
Contact the study team
- Lorenzo Cohen, MD · Phone: (713) 745-4260
Official record on ClinicalTrials.gov — NCT05766891
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.